Published in Cochrane Database Syst Rev on January 25, 2005
A Statewide Intervention to Reduce Use of Unproven or Ineffective Breast Cancer Care | NCT02831439
Benefit of semiannual ipsilateral mammographic surveillance following breast conservation therapy. Radiology (2012) 2.07
Comparing hospital and telephone follow-up after treatment for breast cancer: randomised equivalence trial. BMJ (2009) 1.95
Are primary care providers prepared to care for survivors of breast cancer in the safety net? Cancer (2014) 1.77
Diagnosis of second breast cancer events after initial diagnosis of early stage breast cancer. Breast Cancer Res Treat (2010) 1.29
Alternative methods of follow up in breast cancer: a systematic review of the literature. Br J Cancer (2007) 1.17
Interdisciplinary GoR level III Guidelines for the Diagnosis, Therapy and Follow-up Care of Breast Cancer: Short version - AWMF Registry No.: 032-045OL AWMF-Register-Nummer: 032-045OL - Kurzversion 3.0, Juli 2012. Geburtshilfe Frauenheilkd (2013) 1.14
Yield of clinical and radiographic surveillance in patients with resected pancreatic adenocarcinoma following multimodal therapy. HPB (Oxford) (2012) 1.09
Personalised cancer follow-up: risk stratification, needs assessment or both? Br J Cancer (2012) 0.98
Breast cancer subtype and stage are prognostic of time from breast cancer diagnosis to brain metastasis development. J Neurooncol (2017) 0.96
Use of imaging and biomarker tests for posttreatment care of early-stage breast cancer survivors. Cancer (2013) 0.96
Effectiveness of psychoeducational support on quality of life in early-stage breast cancer patients: a systematic review and meta-analysis of randomized controlled trials. Qual Life Res (2013) 0.89
Proposed follow up programme after curative resection for lower third oesophageal cancer. World J Surg Oncol (2010) 0.87
Provider perceptions and expectations of breast cancer posttreatment care: a University of California Athena Breast Health Network project. J Cancer Surviv (2013) 0.86
Post-operative breast cancer patients diagnosed with skeletal metastasis without bone pain had fewer skeletal-related events and deaths than those with bone pain. BMC Cancer (2010) 0.86
Improving the quality and efficiency of follow-up after curative treatment for breast cancer--rationale and study design of the MaCare trial. BMC Cancer (2007) 0.83
Optimal management of bone metastases in breast cancer patients. Breast Cancer (Dove Med Press) (2011) 0.83
Imaging surveillance of patients with breast cancer after primary treatment: current recommendations. Korean J Radiol (2015) 0.83
Promoting quality and evidence-based care in early-stage breast cancer follow-up. J Natl Cancer Inst (2014) 0.82
Thyroid cancer survivors' perceptions of survivorship care follow-up options: a cross-sectional, mixed-methods survey. Support Care Cancer (2015) 0.80
The reality in the follow-up of breast cancer survivors: survey of Korean Breast Cancer Society. Ann Surg Treat Res (2015) 0.79
Follow-up after treatment for breast cancer: Practical guide to survivorship care for family physicians. Can Fam Physician (2016) 0.79
Underuse of long-term routine hospital follow-up care in patients with a history of breast cancer? BMC Cancer (2011) 0.78
The reality in the surveillance of breast cancer survivors-results of a patient survey. Breast Cancer (Auckl) (2008) 0.78
Guidelines, guidelines and more guidelines: and we still do not know how to follow-up patients with breast cancer. World J Surg Oncol (2005) 0.78
Should breast cancer survivors be excluded from, or invited to, organised mammography screening programmes? BMC Health Serv Res (2011) 0.78
Models of care for early-stage breast cancer in Canada. Curr Oncol (2011) 0.77
Breast cancer follow-up strategies in randomized phase III adjuvant clinical trials: a systematic review. J Exp Clin Cancer Res (2013) 0.76
The cost of cancer care--balancing our duties to patients versus society: are they mutually exclusive? Oncologist (2013) 0.76
Fine needle aspiration cytology of lymph nodes in breast cancer follow-up is a feasible alternative to watchful waiting and to histology. BMC Womens Health (2015) 0.75
Imaging tests in staging and surveillance of non-metastatic breast cancer: changes in routine clinical practice and cost implications. Br J Cancer (2017) 0.75
Is symptom-oriented follow-up still up to date? Breast Care (Basel) (2013) 0.75
Patterns of diagnostic imaging and associated radiation exposure among long-term survivors of young adult cancer: a population-based cohort study. BMC Cancer (2015) 0.75
Manual of Recommendations for the Diagnosis, Therapy, and Follow-Up of Patients with Breast Cancer of the Tumor Center Munich - a Regional Hands-On Publication. Breast Care (Basel) (2008) 0.75
AGO Recommendations for Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer. Update 2011. Breast Care (Basel) (2011) 0.75
The diagnostic value of 18F-FDG PET/CT in association with serum tumor marker assays in breast cancer recurrence and metastasis. Biomed Res Int (2015) 0.75
Imaging Radiation Doses and Associated Risks and Benefits in Subjects Participating in Breast Cancer Clinical Trials. Oncologist (2015) 0.75
Breast cancer "tailored follow-up" in Italian oncology units: a web-based survey. PLoS One (2014) 0.75
Impact on Survival of Regular Postoperative Surveillance for Patients with Early Breast Cancer. Cancer Res Treat (2015) 0.75
[Gynecological cancers in patients with inflammatory rheumatic diseases]. Z Rheumatol (2016) 0.75
General and abdominal adiposity and risk of death in Europe. N Engl J Med (2008) 14.49
European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr (2002) 8.77
Practice guidelines developed by specialty societies: the need for a critical appraisal. Lancet (2000) 8.10
The fission yeast cdc18+ gene product couples S phase to START and mitosis. Cell (1993) 6.25
Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study. Br J Cancer (2001) 5.36
A case-control study of the efficacy of a non-randomized breast cancer screening program in Florence (Italy). Int J Cancer (1986) 4.11
Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women. J Clin Oncol (1998) 3.65
Relative validity and reproducibility of a food frequency dietary questionnaire for use in the Italian EPIC centres. Int J Epidemiol (1997) 3.39
Consumer participation in research and health care. BMJ (1997) 3.38
What contributions do languages other than English make on the results of meta-analyses? J Clin Epidemiol (2000) 3.37
Founder mutations in BRCA1 and BRCA2 genes. Ann Oncol (2007) 3.26
Completeness of reporting of trials published in languages other than English: implications for conduct and reporting of systematic reviews. Lancet (1996) 3.17
A quality assessment of randomized control trials of primary treatment of breast cancer. J Clin Oncol (1986) 3.14
Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr Relat Cancer (2005) 3.04
Intake of macronutrients and risk of breast cancer. Lancet (1996) 2.81
High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability. Am J Pathol (1999) 2.80
Benefits and costs of screening and treatment for early breast cancer. Development of a basic benefit package. JAMA (1995) 2.62
McrBC: a multisubunit GTP-dependent restriction endonuclease. J Mol Biol (1992) 2.51
Randomized clinical trials on medical treatment of glaucoma. Are they appropriate to guide clinical practice? Arch Ophthalmol (1993) 2.44
Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study. Diabetologia (2011) 2.43
XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects. Carcinogenesis (2001) 2.35
Reconstitution of simian virus 40 DNA replication with purified proteins. Proc Natl Acad Sci U S A (1990) 2.32
Quality, evolution, and clinical implications of randomized, controlled trials on the treatment of lung cancer. A lost opportunity for meta-analysis. JAMA (1989) 2.18
A case-control study of gastric cancer and diet in Italy. Int J Cancer (1989) 2.17
Quality of systematic reviews used in guidelines for oncology practice. Ann Oncol (2006) 2.15
Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis. Am J Pathol (2001) 2.13
Overexpression of folate binding protein in ovarian cancers. Int J Cancer (1997) 2.13
HPV in oral squamous cell carcinoma vs head and neck squamous cell carcinoma biopsies: a meta-analysis (1988-2007). Ann Oncol (2008) 1.99
Predictors of delayed gastric emptying in diabetes. Diabetes Care (2001) 1.98
Pattern of cancer risk in persons with AIDS in Italy in the HAART era. Br J Cancer (2009) 1.95
Consumption of sweet beverages and type 2 diabetes incidence in European adults: results from EPIC-InterAct. Diabetologia (2013) 1.93
Interaction between replication forks and topoisomerase I-DNA cleavable complexes: studies in a cell-free SV40 DNA replication system. Cancer Res (1993) 1.88
Age at menarche in relation to adult height: the EPIC study. Am J Epidemiol (2005) 1.88
Disclosure of breast cancer diagnosis: patient and physician reports. GIVIO (Interdisciplinary Group for Cancer Care Evaluation, Italy) Ann Oncol (1991) 1.87
Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trials. Ann Oncol (1997) 1.85
Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis. Gut (2005) 1.84
Effectiveness of antibiotic prophylaxis in critically ill adult patients: systematic review of randomised controlled trials. BMJ (1998) 1.75
Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype. Ann Oncol (2002) 1.74
A European version of the Appropriateness Evaluation Protocol. Goals and presentation. The BIOMED I Group on Appropriateness of Hospital Use. Int J Technol Assess Health Care (1999) 1.73
On the spin trapping and ESR detection of oxygen-derived radicals generated inside cells. Proc Natl Acad Sci U S A (1986) 1.72
Biologically active metal-independent superoxide dismutase mimics. Biochemistry (1990) 1.72
Factors affecting in-hospital heat-related mortality: a multi-city case-crossover analysis. J Epidemiol Community Health (2008) 1.70
Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial. Br J Cancer (2006) 1.70
Multiple approach to the exploration of genotype-phenotype correlations in familial adenomatous polyposis. J Clin Oncol (2003) 1.69
Intake of selected micronutrients and risk of colorectal cancer. Int J Cancer (1997) 1.68
Chronic effects of therapeutic irradiation for localized prostatic carcinoma on anorectal function. Int J Radiat Oncol Biol Phys (2000) 1.64
Factors affecting splanchnic haemodynamics in Crohn's disease: a prospective controlled study using Doppler ultrasound. Gut (1998) 1.64
Short term increase in risk of breast cancer after full term pregnancy. BMJ (1988) 1.63
The impact of patient management guidelines on the care of breast, colorectal, and ovarian cancer patients in Italy. Med Care (1991) 1.62
Reliability study of the European appropriateness evaluation protocol. Int J Qual Health Care (1999) 1.59
Bromodeoxyuridine in tumors and chromosomes detected with a monoclonal antibody. J Clin Invest (1983) 1.59
Do nitroxide antioxidants act as scavengers of O2-. or as SOD mimics? J Biol Chem (1996) 1.59
Clinical characteristics and overall survival in genitourinary sarcomas treated with curative intent: a multicenter study. Eur Urol (2004) 1.56
Intrapleural photodynamic therapy: results of a phase I trial. Ann Surg Oncol (1994) 1.56
Petrous bone cholesteatoma. Skull Base Surg (1993) 1.55
The impact of the summer 2003 heat waves on mortality in four Italian cities. Euro Surveill (2005) 1.55
Oxoammonium cation intermediate in the nitroxide-catalyzed dismutation of superoxide. Proc Natl Acad Sci U S A (1992) 1.54
DNA repair polymorphisms and cancer risk in non-smokers in a cohort study. Carcinogenesis (2005) 1.54
Consumption of vegetables, fruit and other plant foods in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohorts from 10 European countries. Public Health Nutr (2002) 1.53
Inhibition of oxygen-dependent radiation-induced damage by the nitroxide superoxide dismutase mimic, tempol. Arch Biochem Biophys (1991) 1.53
Prospective screening of dyspeptic patients by Helicobacter pylori serology: a safe policy? The Italian Helicobacter pylori Study Group. Endoscopy (1997) 1.52
Incessant ovulation and ovarian cancer: a critical approach. Int J Epidemiol (1983) 1.51
Accuracy and reliability of frozen section diagnosis in a series of 672 nonpalpable breast lesions. Am J Clin Pathol (1995) 1.51
Systematic review: green tea and gastrointestinal cancer risk. Aliment Pharmacol Ther (2004) 1.49
Essential requirements for practice guidelines at national and local levels. Neurol Sci (2004) 1.49
The Frontal Assessment Battery (FAB): normative values in an Italian population sample. Neurol Sci (2005) 1.48
Relationship of alcohol intake and sex steroid concentrations in blood in pre- and post-menopausal women: the European Prospective Investigation into Cancer and Nutrition. Cancer Causes Control (2006) 1.47
A meta-analysis of trials on aldose reductase inhibitors in diabetic peripheral neuropathy. The Italian Study Group. The St. Vincent Declaration. Diabet Med (1996) 1.46
Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis. Br J Cancer (2006) 1.46
The risk of bias from omitted research. BMJ (2000) 1.43
Left atrial thrombus and spontaneous echo-contrast in nonanticoagulated mitral stenosis. A transesophageal echocardiographic study. Chest (1993) 1.43
Do specialists do it better? The impact of specialization on the processes and outcomes of care for cancer patients. Ann Oncol (1998) 1.43
Persistent transactivation of EGFR and ErbB2/HER2 by protease-activated receptor-1 promotes breast carcinoma cell invasion. Oncogene (2008) 1.42
The consequences of under-use of coronary revascularization; results of a cohort study in Northern Italy. Eur Heart J (2001) 1.41
The impact of cancer treatment guidelines on actual practice in Italian general hospitals: the case of ovarian cancer. Ann Oncol (1990) 1.40
[Anterior chamber migration of intravitreal dexamethasone implant (Ozurdex®) in pseudophakic eyes: report of three cases]. J Fr Ophtalmol (2013) 1.40
Antithrombotic drugs in secondary stroke prevention among a community dwelling older population. J Neurol Neurosurg Psychiatry (2003) 1.40
Facial nerve neuromas: diagnosis and management. Am J Otol (1995) 1.40
IGF-I, IGFBP-3 and breast cancer risk in women: The European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer (2006) 1.39
Baseline and CRH-stimulated ACTH and cortisol levels after administration of the peroxisome proliferator-activated receptor-gamma ligand, rosiglitazone, in Cushing's disease. J Endocrinol Invest (2004) 1.39
Mediterranean diet and type 2 diabetes risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study: the InterAct project. Diabetes Care (2011) 1.39
Prolonging proton pump inhibitor-based anti-Helicobacter pylori treatment from one to two weeks in duodenal ulcer: is it worthwhile? Dig Liver Dis (2000) 1.39
Animal foods, protein, calcium and prostate cancer risk: the European Prospective Investigation into Cancer and Nutrition. Br J Cancer (2008) 1.38
Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy. Ital J Gastroenterol Hepatol (1997) 1.38
Leukocyte alkaline phosphatase (LAP). A useful marker of zinc status in beta-thalassemic patients. Am J Pediatr Hematol Oncol (1987) 1.38
Superoxide modulates the oxidation and nitrosation of thiols by nitric oxide-derived reactive intermediates. Chemical aspects involved in the balance between oxidative and nitrosative stress. J Biol Chem (1997) 1.37
Expression of folate binding protein as a prognostic factor for response to platinum-containing chemotherapy and survival in human ovarian cancer. Int J Cancer (1998) 1.36
Plasma carotenoids as biomarkers of intake of fruits and vegetables: individual-level correlations in the European Prospective Investigation into Cancer and Nutrition (EPIC). Eur J Clin Nutr (2005) 1.36
Mediterranean dietary pattern and cancer risk in the EPIC cohort. Br J Cancer (2011) 1.35
Breast cancer genome-wide association studies: there is strength in numbers. Oncogene (2011) 1.34
Polymorphisms of genes coding for insulin-like growth factor 1 and its major binding proteins, circulating levels of IGF-I and IGFBP-3 and breast cancer risk: results from the EPIC study. Br J Cancer (2006) 1.34
Patterns of genomic instability in gastric cancer: clinical implications and perspectives. Ann Oncol (2006) 1.33
Stimulation by nitroxides of catalase-like activity of hemeproteins. Kinetics and mechanism. J Biol Chem (1996) 1.33
Phytochemical compounds involved in the anti-inflammatory effect of propolis extract. Fitoterapia (2002) 1.33
A case-control study of gastric cancer and diet in Italy: II. Association with nutrients. Int J Cancer (1990) 1.32